Zansecimab Completed Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02597036A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors